Cargando…
Bortezomib and metformin opposingly regulate the expression of hypoxia-inducible factor alpha and the consequent development of chemotherapy-induced painful peripheral neuropathy
Chemotherapy-induced painful peripheral neuropathy is a significant clinical problem that is associated with widely used chemotherapeutics. Unfortunately, the molecular mechanisms by which chemotherapy-induced painful peripheral neuropathy develops have remained elusive. The proteasome inhibitor, bo...
Autores principales: | Ludman, Taylor, Melemedjian, Ohannes K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509977/ https://www.ncbi.nlm.nih.gov/pubmed/31041875 http://dx.doi.org/10.1177/1744806919850043 |
Ejemplares similares
-
Bortezomib-induced aerobic glycolysis contributes to chemotherapy-induced painful peripheral neuropathy
por: Ludman, Taylor, et al.
Publicado: (2019) -
Acupuncture for Bortezomib-Induced Peripheral Neuropathy: Not Just
for Pain
por: Zhi, W. Iris, et al.
Publicado: (2018) -
Pathological Mechanisms of Bortezomib-Induced Peripheral Neuropathy
por: Yamamoto, Shota, et al.
Publicado: (2021) -
Vascularization of the dorsal root ganglia and peripheral nerve of the mouse: Implications for chemical-induced peripheral sensory neuropathies
por: Jimenez-Andrade, Juan M, et al.
Publicado: (2008) -
The protective effects of lafutidine for bortezomib induced peripheral neuropathy
por: Tsukaguchi, Machiko, et al.
Publicado: (2013)